Work

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.05.005

Authors: Ailin Li, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, Taylor R. Cushman, Mauricio S. Caetano, Xiaohong Wang, David R. Valdecanas, Sharareh Niknam, Ahmed I. Younes, Guang Li, Wendy A. Woodward, Maria Angelica Cortez, James W. Welsh

Institutions: First Hospital of China Medical University, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Doctors Cancer Foundation, Lung Cancer Research Foundation, Robert O. and Annamae Orr Family Foundation, National Natural Science Foundation of China, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G111615301, ZEB2基因3’UTR区SNPs与非小细胞肺癌放射敏感性的相关性及机制研究, Cancer Center Support Grant

OpenAlex ID: W2800712256

FWCI: 3.032

Cites: 41

Cited by: 84

Related to: 10